GSK’s new pharma head to join in September after AstraZeneca tussle

LONDON (Reuters) - GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca.
مشاور سئو

فالوور اینستاگرام

فالوور اینستاگرام